Gladko

30/11/2020

04/02/2019

Transplantation of fetal stem cell suspensions in rehabilitation period in postinfarction cardiosclerosis and hypertension patients has positive effects on overall health as well as on rheological (flow) properties of blood. These effects have been proved by clinical data of postinfarction and other ischemic heart disease patients followed up at Cell Therapy.

When using fetal cell suspensions containing stem cells, syndrome of early posttransplantation improvements is observed in all patients. The major manifestations of this syndrome include decreased weakness, improved overall health and appetite, normalized sleep formula, positive changes in psychoemotional sphere, such as reduced manifestation of somatic depression, improved emotional state, thinking, memory and hope for recovery. 80% of patients report gradual decrease of blood pressure, at first, taking the pretransplantation dose of antihypertensive drugs, but 2-4 weeks after the stem cell transplantation, 45-50% of patients reduce the dose of nitrates and antihypertensive drugs. Also, in all cases observed is gradual decrease and normalization of cholesterol, triglycerides, as well as low and very low density lipoproteins levels. Almost all our patients improve rheological properties of blood that can be related to the increase in prothrombin index and prolongation of coagulation time.

Due to formation of the alternative (additional) systems of collateral vessels in the cardiac muscle, tissue trophism significantly improves, manifestations of ischemia become less expressed, frequency and intensity of angina attacks decrease, and metabolism in myocardium improves.

Improvement in overall health and better ability to work motivate patients to extend their physical activities and return to their working career. All this taken as a whole improves life quality of ischemic heart disease patients and significantly (by 35%) extends their life span.

04/02/2019

Stem Cell Therapy offers a new, advanced, patented fetal stem cell transplant-based method for diabetes mellitus that has been proved effective in treating 1 and 2 types of diabetes, and in preventing diabetes-related complications, which usually affect the eyes, arteries, kidneys and so on.

In combination with traditional treatment of type 1 diabetes, fetal stem cells (FSC) can help:

end the auto-aggression of cell-mediated immunity factors against β-cells;
prevent the destruction of β-cells that are functional at the time of the treatment;
restore the patient’s own β-cells and improve their functional capacity;
prevent diabetes-related complications affecting eyes, kidneys, peripheral nerves, and so on;
improve insulin-dependent tissue condition.
In type 2 treatment, fetal stem cells can help:

restore peripheral tissue sensitivity to insulin;
reduce atherogenic hyperinsulinemia;
decrease the production of glucose and pathologic lipids by liver cells;
improve the condition of arterial walls, which is vital for the prevention of atherosclerosis and complications arising from it;
reduce the dose of hypoglycemic medications.
Within last years, has been treated hundreds of patients with both type 1 and type 2 diabetes, with improvements reported in 65% and 74% of cases correspondingly, such as:

stabilized carbohydrate metabolism, resulting in more stable blood sugar levels and a gradual decrease of HbA1C;
normalized blood counts;
longer periods of remission;
reduced severity and frequency of diabetes-related complications;
higher exercise power;
improved sexual capacity;
boosted immunity;
better overall life quality.

If recommendations are followed and the patient’s lifestyle is healthy, a gradual decrease in hypoglycemic medication doses is also possible.

04/02/2019

Fetal stem cell treatment is not an alternative to standard protocols of treating cancer. Stem cell therapy is possible only after surgery and/or traditional chemo- and/or radiotherapy, in case they are indicated to the patient.
We accept for treatment cancer patients with stabilized condition proved by results of instrumental and laboratory findings – there should be no primary tumor growth or new metastasis formation.

As conventional cancer treatment has many side effects, stem cell treatment is aimed mainly at:
• Partial restoration of anti-tumor immunity and haemopoesis;
• Improvement in patient’s quality of life – reduced weakness, better overall condition, both physical and psycho-emotional.

During the first month after stem cell treatment, our patients may observe the following effects:
• improved overall condition and appetite;
• diminished weakness and sweating;
• increased capacity to work and self-care ability;
• better emotional status, cognitive abilities and memory.

Within one to two months after fetal stem cells transplantation, other positive effects develop (some of them translate into improved laboratory findings), in particular:
• improved haemopoesis;
• improved immunological profile;
• reduced levels of inflammatory markers;
• higher quality of life.

Fetal stem cell therapy contributes to formation of anti-tumor immunity, which is crucial for preventing relapse and metastatic process. However, stem cell treatment is possible only after traditional treatment.

04/02/2019

According to medical statistics, arterial hypertension, or elevated blood pressure, is the main cause of death all over the world along with cerebral atherosclerosis. Cell Center offers fetal stem cell therapy in a combined treatment of arterial hypertension aimed at improving the condition of arterial walls and blood pressure stabilization.

Patients with primary arterial hypertension with frequent arterial crises receive transplantation of fetal stem cells of ectodermal and mesenchymal origin. Stem cells administered into recipient’s body get into the cardiac muscle and produce various biologically active substances, such as growth factors, cytokines, etc., which results in improved heart functioning. Under the influence of the microenvironment, mesenchymal stem cells develop into a phenotype of cardiomyocytes. Pre-neuronal stem cells normalize nervous vascular control resulting in crisis prevention. That is why cell therapy can be used to restore the functional properties of the heart muscle.

Prior to transplantation, continuous hypotensive therapy regimen is selected; that allows for preventing hypertensive crises, and diastolic pressure stabilizes at the level no higher than 90 mm Hg.
Stem cell therapy allows to completely restore the integrity of the vascular tissues, their elasticity, conductivity and strength at the biological level. It has the following positive effects in treatment of arterial hypertension:
• vascular system improvement: stem cells begin to produce angiogenic and anti-inflammatory factors;
• partial replacement of destroyed or damaged cells;
• improved cerebral vessel functioning and cardiac blood supply;
• increased elasticity and permeability of blood vessels;
• improved delivery of oxygen and nutritional elements to all organs and tissues—brain, heart, liver, kidneys—due to better blood flow.

Within 3–5 months after fetal stem cell transplantation, all patients demonstrate stable decline in blood pressure and reduction of hypotensive therapy by approximately 50%.

All patients note positive treatment effects such as disappearance of headache, stabiliziation and normalization of blood pressure and sleep, improved mental ability and sexual potency (both in men and women), return of vivacity – signs of rejuvenation.

Thus, stem cell therapy improves the condition of the vascular system of the human body. Full disclosure of stem cells’ regenerative potential usually occurs within 2-3 months after transplantation. To intensify the effects of cell therapy, patients are advised to improve lifestyle, get rid of bad habits, decrease intake of salt and start exercising.